证券交易开户Novartis CEO sets aside $700 million to settle doctor bribery lawsuit

  • 时间:
  • 浏览:5
  • 来源:配资公司交易账号-我想买些中泰证券股票配资请问那个配资平台比较有名
FI证券交易开户证券交易开户lE PHO证券交易开户tO: CEO Vas Narasimhan of Swiss drugmaker Novartis addresses the company's annual news conference in Basel, Switzerland January 30, 2019. REUTERS/Arnd Wiegmann/File Photo

ZURICH (Reuters) - Novartis (NOVN.S) Chief Executive Vas Narasimhan set aside $700 million to settle a U.S. doctor bribery lawsuit, as the Swiss drugmaker seeks to close the chapter on allegedly aggressive business practices that exposed it to litigation risks.

&ld证券交易开户quo;Consistent with our efforts to resolve our legacy compliance-related allegations, right now we’re working in settlement discussions to resolve the civil suit...on speaker programs and other promotional events that happened between 2002 and 2011,” Narasimhan said on a conference call on Thursday.

“We’ve provisioned approximately $700 million for any potential settlement.”

Narasimhan outlined the settlement talks after Novartis raised 2019 sales and profit guidance, on accelerating sales of drugs including Entresto for heart failure and Cosentyx for inflammatory disorders and as its biosimilar copies of rivals’ top-selling medicines increase their market share in Europe.